Even if NGAL expression is highly variable in an extended panel of colon carcinoma cell lines, disease free survival (DFS) and overall survival (OS) of colon cancer patients dramatically decrease in NGAL positive tumor samples [38]. This evidence concerns the gene LCN2 and colonic neoplasm.